MedTrace Logo

Great Auricular Nerve Block for Children Undergoing Tympanomastoid Surgery

NCT01638052 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2021-08-04

Study results available
· View outcomes & findings →

Summary

The investigators goal is to determine the efficacy and duration of analgesia with the addition of Clonidine, an alpha-2 agonist, to local anesthetic blockade using bupivacaine, of the great auricular nerve in children undergoing tympanomastoid surgery.

Conditions

  • Tympanomastoid Surgery
  • Cochlear Implant
  • Mastoidectomy
  • Cholesteatoma

Interventions

DRUG

0.25% Bupivacaine + Clonidine

Patients will receive 2mL of 0.25% bupivacaine with 2mcg/ml of clonidine

Sponsors & Collaborators

  • Ann & Robert H Lurie Children's Hospital of Chicago

    lead OTHER

Principal Investigators

  • Santhanam Suresh, MD · Ann & Robert H Lurie Children's Hospital of Chicago

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-02-28
Primary Completion
2008-03-31
Completion
2008-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01638052 on ClinicalTrials.gov